Page last updated: 2024-12-06
hdta
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
HDTA: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 74209 |
| SCHEMBL ID | 239081 |
| MeSH ID | M0086000 |
Synonyms (29)
| Synonym |
|---|
| EN300-19832 |
| einecs 216-642-1 |
| 1,6-hexanediamine-n,n,n',n'-tetraacetic acid |
| RS-0115 |
| hdta |
| 1,6-diaminohexane-n,n,n',n'-tetraacetic acid |
| hexamethylenediamine-n,n,n',n'-tetraacetic acid |
| 1,6-diaminohexane-n,n,n',n'-tetraacetic acid, 97% |
| 2-[6-[bis(carboxymethyl)amino]hexyl-(carboxymethyl)amino]acetic acid |
| 2,2',2'',2'''-(hexane-1,6-diyldinitrilo)tetraacetic acid |
| AKOS005109703 |
| hexamethylenediaminetetraacetic acid |
| D2019 |
| 1633-00-7 |
| A810465 |
| 2,2',2'',2'''-(hexane-1,6-diylbis(azanetriyl))tetraacetic acid |
| 2-({6-[bis(carboxymethyl)amino]hexyl}(carboxymethyl)amino)acetic acid |
| FT-0633721 |
| SCHEMBL239081 |
| F1908-0154 |
| glycine, n,n'-1,6-hexanediylbis[n-(carboxymethyl)- |
| hexamethylenediamine-n,n,n',n'-tetracetic acid |
| mfcd00004292 |
| 1,6-diaminohexane-n,n,n,n-tetraacetic acid |
| DTXSID00936810 |
| D89974 |
| 2,2',2'',2'''-(hexane-1,6-diylbis(azanetriyl))tetraaceticacid |
| BAA63300 |
| 1,6-diaminohexane-n,n,n(2),n(2)-tetraacetic acid |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 48.72
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (48.72) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||